MassDevice.com +5 | The top 5 medtech stories for March 23, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. InVivo wins Health Canada nod for cervical neuro-spinal scaffold trial InVivo Therapeutics said today it won Health Canada approval to initiate a clinical study of its neuro-spinal scaffold in patients with acute, complete AIS A cervical spinal cord injuries. The Cambridge, Mass.-based company said it is in late stage conversations with several site research ethics boards, and expects to announce the 1st Canadian site for the study “in the coming weeks.” Read more 4. Ethicon closes Torax Medical buy Johnson & Johnson subsidiary Ethicon said today it closed its acquisition of Torax Medical, and its Linx acid reflux treatment portfolio, for an undisclosed amount. The Linx system from Shoreview, Minn.-based Torax is an implant composed of interlinked titanium beads with magnetic cores that augments the esophageal sphincter’s barrier function to prevent reflux in patients with gastro-esophageal reflux disease. Torax is also developing a similar device, Fenix, designed to treat fecal incontinence. Read more 3. Supreme Court declines review of Retractable Tech c...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news